Citations 1
Phase II trial of atezolizumab before and after definitive chemoradiation for unresectable stage III NSCLC.
Ross, Helen J. , Kozono, David , Urbanic, James J., DuFrane, Carter, Bāra, Ilze, Gandhi, Mayank , Schulze, Katja , Brockman, Jane Michelle, Wang, Xiaofei F., Stinchcombe, Tom, Kozono, David E , Williams, Terence M. , Vokes, Everett E. , Stinchcombe, Thomas E.
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS8585-TPS8585
